Regulation of gene expression with Khavinson Peptides

Regulation of gene expression with Khavinson Peptides


It was revealed that fluorescein isothiocyanate -labeled (FITC) small peptides penetrate into cytoplasm, nucleus and nucleolus of the HeLa cell. It is known that the nucleus of eukaryotic cells has a system of nucleopores formed by protein complexes – nucleoporins. The inner diameter of the nucleopores is about 50 nm. Thus, they are permeable for the diffusing molecules with a molecular weight up to 3,5 kDa. Thus, small peptides by their physical-chemical characteristics, (charge, size, hydrophobicity) can penetrate the cytoplasmic and nuclear membrane of the cell and possibly interact with DNA.

According to the data obtained by physical methods (UV spectroscopy, circular dichroism, viscosimetry, atomic force microscopy) and molecular modelling; signal peptides are capable of binding to DNA in solution. This process takes several hours without almost any electrostatic force. The formation between the major groove of DNA with nitrogenous bases and peptide leads to a destabilization of the secondary structure of macromolecule. According to results from the spectrophotometry, in the ultraviolet region of the spectrum in the mixture of the peptide (AEDG and double-stranded DNA) there was registered a concentration-dependent hyperchromic effect (an increase in the optical density of the DNA solution at a wavelength of 260 nm). This hyperchromic effect proves that there is a partial destruction of hydrogen bonds between the nucleotide pairs of the double helix and local separation of the DNA chains (allosteric conformational change).

It was established through experiments that the separation of chains (melting) of free synthetic DNA occurs at a temperature of 69.50 C. Nevertheless in the DNA-peptide (AEDG) system this melting took place at a temperature of 280 C and was characterized by an almost two-fold decrease in the enthalpy and entropy values. This shows that there is a thermodynamically easier way to melt DNA strands at the temperature, which is adequate to the thermal regimes of biochemical processes in the majority of living organisms. It also shows that separation of DNA strands at physiological temperatures is not a denaturation, instead it is the initiation of protein synthesis process.

These theoretical and experimental data allowed to propose a model of peptide-DNA interactions in case of Khavinson peptides. Moreover these data enable to create a stable peptide-DNA complex. Analysis of the main physical and chemical parameters of this complex, (the number of hydrogen bonds, hydrophobic and electrostatic interactions, energy of minimization of the DNA-peptide complex) was performed using molecular modelling. It allowed to determine quantitative characteristics of the DNA-peptide complex [Molecular Operating Environment; Chemical Computing Group Inc (2012) 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2012]. Based on these calculations a three-dimensional model of the interaction of peptide AEDG with the DNA ATTTC site was created.

The experiments revealed a specific binding of peptides with oligonucleotides which may be particularly important for the epigenetic mechanism for regulation of gene expression. Interaction of small peptides, particularly with single stranded DNA regions, may specifically control expression of genes.

Short peptides were found to modulate the activity of wheat seedling endonucleases. This modulation of endonucleases activity probably happens due to the site-specific DNA-peptide binding which protects DNA against enzymatic hydrolysis. Then in turn, the modulation of endonucleases activity by peptides is modulated by histones. Chromatin histones in the nucleus may affect binding of DNA to small peptides. In addition, some peptides appear to control hydrolysis of DNA by endonucleases, at the level of interaction for a peptide with an enzyme.

It was revealed that small peptides activate heterochromatin in cell nuclei in elderly people and contribute to the ‘release’ of genes, repressed as a result of heterochromatinization of euchromatic regions of chromosomes that occurs with aging.

Structural condensation of chromatin is in close correlation with the functional heterogeneity. It was revealed that with aging the heterochromatinization becomes more intensive and this correlates with inactivation of previously active genes. Tightly condensed heterochromatic regions of chromosomes are genetically inactivated and have a slower replication. The decondensed (euchromatic) regions of chromosomes are always actively functioning. Regulatory peptides increase concentration of euchromatin in the nucleus. It means that more genes become available for transcription, which also occurs faster. As a result the protein synthesis also increases. The more euchromatin there is in the nucleus, the more intensive the protein synthesis in the cell is. The results of this experiment lead to the conclusion that heterochromatinization is a reversible process, with important biological outcomes.

It was revealed that administration of peptides KE and AEDG to transgenic mice caused a 2-3.6-fold suppression of HER-2/neu gene expression (human breast cancer) when compared to the control group. This suppression is accompanied by a significan treduction of the tumor diameter (Fig. 2).

It was shown that the addition of peptide AEDG to the cultural medium of human lung fibroblasts induces telomerase gene expression and contributes to a 2.4-fold lengthening of telomeres. Activation of gene expression is accompanied by a growing number of cellular divisions by 42.5% (Fig. 3). It was revealed that addition of tetrapeptide Ala-Glu-Asp-Gly to the cultural medium of human lung fibroblasts induces telomerase gene expression and contributes to a 2.4-fold lengthening of telomeres. Activation of gene expression is accompanied by a growing number of cellular divisions (by 42.5%), which is the evidence of Hayflick’s limit overcoming. This fact fully correlates with earlier stated maximum increase of animal life span (43,3%) after administration of this peptide.

The effect of peptides KE, EW, AEDG, AEDP on the expression of 15,247 murine heart and brain genes was studied with the employment of DNA-microarray technology. It was revealed that each peptide specifically regulates a particular group of genes. The result of this experiment strengthens the theory that peptides have a regulatory function for gene activity. It was also shown that the dipeptide KE, had an immunomodulating activity, regulating gene interleukin-2 expression in blood lymphocyte.

In the cell cultures of human bronchial epithelium, tetrapeptide AEDL activates the expression of genes of bronchial epithelium differentiation Nkx2.1, SCGB1A1, SCGB3A2, FoxA1, FoxA2. This peptide also increases expression of genes MUC4, MUC5АС, SftpA1, which reduces the frequency of chronic bronchitis. In the cell cultures of human pancreas tetrapeptide KEDW increased expression of differentiation genes PDX1, NGN3, PAX6, FOXA2, NKX2.2, NKX6.1, PAX4 and decreased expression of genes MNX1 HOXA3 Methylation profile of PDX1, PAX6, NGN3, NKX2-1, SCGB1A1 genes promoter regions in pancreas and bronchial epithelium cells changes with aging and under the influence of peptides which correlates with alterations in the levels of the genes expression. Methylation of gene promoter regions may be modulated under the influence of peptides. Promoter zone of gene FOXA2 in pancreas cells contains small number of methylated CpG-sites which methylation process changes with aging and is under the direct influence of peptide KEDW. The changes in the character of methylation of promoter zones may serve the reason for age-related and peptide induced alterations in the levels of PDX1, PAX6, NGN3 genes expression in pancreas cells and NKX2-1, SCGB1A genes expression in bronchial cells.

It was revealed that the tripeptide EDG regulates mRNA expression of various genes in the model of induced gastric ulcers in rats. Peptide EDG decreased synthesis of mRNA genes which encode cellular metabolism proteins SOD, TNFα, Cox-2.

Thus, specific (complementary) DNA-peptide interactions may have played an important role for the earliest stages of the origin of life and its evolution by epigenetic control of cell functioning.

Application of Khavinson peptides

Application of Khavinson Peptides


In a randomized comparative study which lasted for 15 years, in elderly people with premature cardiovascular aging, it was found that the administration of the medicinal peptide preparation ‘Epithalamin’ slowed down the rate of aging and decreased mortality. By the end of this period 16 of 40 patients in the control group (40%) and 26 of 39 patients treated with Epithalamin (66.7%) were leaving. A long-term application of ‘Epithalamin’ (6 courses over a period of 3-years), also slows down the aging of the cardiovascular system, preventing an age-related increase in the physical stamina, normalizing the diurnal rhythm of melatonin synthesis, as well as carbohydrate and lipid metabolism.

Treatment efficiency was evaluated by shifts in the following parameters: CVS functional age, threshold exercise power, total cholesterol, glucose concentration after overnight fasting and 2 hour after standard glucose tolerance test, plasma melatonin concentration. Threshold execise power (in W) was evaluated by bicycle ergometry using common diagnostic criteria. Cardiovascular system FA was evaluated by the method using mathematical formulas based on the threshold exercise power and haemodynamics at the peak of threshold exercise. The degree of CVS aging was calculated as the difference between functional age and actual age. Oral glucose tolerance test with 75 g glucose was carried out as recommended by the WHO. The geroprotective effect of pineal gland peptides is also confirmed by the decreased mortality rate, shown with the Kaplan-Meier survival curves (Fig. 5).

The peptide preparations of the thymus, (‘Thymalin’, peptides EW and KE) was shown to be effective in the treatment of many diseases and conditions associated with decreased cell immunity and phagocytosis after radiotherapy and chemotherapy in cancer patients. It also had an effect in many other clinical setting such as cases of acute and chronic infectious and inflammatory diseases, overuse of antibiotics, oppression of the regeneration processes in post-traumatic and postoperative complications, obliterating diseases of arteries, chronic liver or prostate diseases, and complex treatment of certain forms of tuberculosis. Application of “Thymalin” in different clinical studies improved immune functions significantly (increased amount of T-lymphocytes, T-lymphocytes-helpers, enhanced reaction of lymphocytes blast-transformation in presence of phytoheamagglutinin and Concanavalin A were registered, as well as reinforced reaction of phagocytosis).

Peptide preparation ‘Cortexin’ is an extract from the cerebral cortex wich exerts a significant neuroprotective effect. This preparation improves memory, stimulates reparative processes and accelerates restoration of ceberal functions after stress. This preparation is also effective in the treatment of craniocerebral injury, cerebral circulatory disorders, viral and bacterial neuroinfections, encephalopathy of different genesis, acute and chronic encephalitis and encephalomyelitis. A particularly high efficiency of this peptide preparation was noted in elderly patients.

A remarkable clinical effect has been observed with the peptide ‘Retinalamin’, which is extracted from the retina of animals. This unique preparation is applied in patients with various degenerative diseases of the retina such as; diabetic retinopathy, involutional degeneration, retinitis pigmentosa and other pathologies. Of particular importance is its ability to restore electrical activity of the retina, moreover this restoration usually correlates with an improvement of visual functions (vision acuity, fields of vision, electro-physiological investigation).

Another peptide preparation which is called ‘Prostatilen’ was extracted from animal prostate gland. This preparation is effective for treatment of chronic prostatitis, adenoma and complications after prostate gland surgery, as well as in different age-related prostate dysfunctions.

It should be emphasized that Khavinson peptides selectively bind to specific DNA sites in vitro. They epigenetically regulate expression of genes, (oncogenes, telomerase gene, interleukins genes, transcription factors genes) as well as the synthesis of proteins – markers of differentiation, proliferation, apoptosis and increase the length of telomeres in somatic cells. These peptides furthermore increase the average lifespan, decrease tumour incidence in animals and decrease human mortality by maintaining endocrine, nervous and immune systems.


For over 40 years our main interest lies in the discovery, design and study of a new group of signal peptide molecules. Learning the mechanisms of action and their role in gene expression, protein synthesis and life extension is the main goal of our multinational research.

Read more here: